Björn Hackanson

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Acute Myeloid Leukemia

Peritoneal Dialysis

Peripheral Blood

Top Venues

International journal of molecular sciences

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Ann-Kristin Schmälter, Phillip Löhr, Maik Konrad, Johanna Waidhauser, Tim Tobias Arndt, Stefan Schiele, Alicia Thoma, Björn Hackanson, Andreas Rank
Alterations in Peripheral Lymphocyte Subsets under Immunochemotherapy in Stage IV SCLC Patients: Th17 Cells as Potential Early Predictive Biomarker for Response. International journal of molecular sciences 25 (10) (2024)
Ann-Kristin Schmälter, Phillip Löhr, Maik Konrad, Johanna Waidhauser, Tim Tobias Arndt, Stefan Schiele, Alicia Thoma, Björn Hackanson, Andreas Rank
Alterations in Peripheral Lymphocyte Subsets under Immunochemotherapy in Stage IV SCLC Patients: Th17 Cells as Potential Early Predictive Biomarker for Response. International journal of molecular sciences 25 (10) (2024)
Gabriele Greve, Geoffroy Andrieux, Pascal Schlosser, Nadja Blagitko-Dorfs, Usama-Ur Rehman, Tobias Ma, Dietmar Pfeifer, Gerhard Heil, Andreas Neubauer, Jürgen Krauter, Michael Heuser, Helmut R Salih, Konstanze Döhner, Hartmut Döhner, Björn Hackanson, Melanie Boerries, Michael Lübbert
In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts. Leukemia (2023)
Jan K Hiller, Claudia Schmoor, Verena I Gaidzik, Charlotte Schmidt-Salzmann, Arzu Yalcin, Mahmoud Abdelkarim, Nadja Blagitko-Dorfs, Konstanze Döhner, Lars Bullinger, Justus Duyster, Michael Lübbert, Björn Hackanson
Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy. Annals of hematology 96 (4) (2017)